Advances in Huntington’s disease diagnostics: development of a standard reference material

References

• International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature409, 860–921 (2001).
   PubMed Web of Science ®Google Scholar
• Jakupciak JP, Wells RD. Gene conversion mediates expansions of CTG/CAG repeats. J. Biol. Chem.275, 40003–40013 (2000).
   PubMedGoogle Scholar
• Bacolla A, Wells RD. Non-B DNA conformations, genomic rearrangements, and human disease. J. Biol. Chem.279, 47411–47414 (2004).
   PubMed Web of Science ®Google Scholar
• Wells RD, Warren ST (Eds). Genetic Instabilities and Hereditary Neurological Disease. Academic Press, CA, USA, 3–12 (1998).
   Google Scholar
• Jakupciak JP, Wells RD. Genetic instabilities of triplet repeat sequences by recombination. Life50, 355–359 (2000).
   Google Scholar
• Wells RD, Dere R, Hebert ML, Napierala M, Son LS. Advances in mechanisms of genetic instability related to hereditary neurological diseases. Nucleic Acids Res.33, 3785–3798 (2005).
   PubMed Web of Science ®Google Scholar
• Pearson CE, Edamura KN, Cleary JD. Repeat instability: mechanisms of dynamic mutations. Nat. Rev. Genet.6, 729–742 (2005).
   PubMed Web of Science ®Google Scholar
• Dorland’s Illustrated Medical Dictionary. 28th Ed. WB Saunders Company, PA, USA (1994).
   Google Scholar
• Rimoin DL, Connor JM, Pyeritz RE (Eds). Emery and Rimoin’s Principles and Practice of Medical Genetics, 3rd Ed. Churchill Livingstone, NY, USA, 2003–2008 (1997).
   Google Scholar
• Harper PS. The epidemiology of Huntington’s disease. Hum. Genet.89, 365–376 (1992).
   PubMedGoogle Scholar
• Potter NT, Spector EB, Prior TW. Technical standards and guidelines for Huntington disease testing. Genet. Med.6, 61–65 (2004).
   PubMedGoogle Scholar
• Wexler NS, Lorimer J, Porter J et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset. Proc. Natl Acad. Sci USA101, 3498–3503 (2004).
   PubMed Web of Science ®Google Scholar
• Bates GP, Harper PS, Jones AL (Eds). Huntington’s disease, 3rd Ed. Oxford University Press, Oxford, UK (2002).
   Google Scholar
• Telenius H, Kremer B, Goldberg YP et al. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat. Genet.6, 409–414 (1994).
   Google Scholar
• The Huntington’s disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell72, 971–983 (1993).
   PubMed Web of Science ®Google Scholar
• American College of Medical Genetics, American Society of Human Genetics (ACMG/ASHG) Huntington Disease Genetic Testing Working Group. Laboratory guidelines for Huntington disease genetic testing. Am. J. Hum. Genet.62, 1243–1247 (1998).
   PubMed Web of Science ®Google Scholar
• Jones AL, Wood JD, Harper PS. Huntington disease: advances in molecular and cell biology. J. Inher. Metab. Dis.20, 125–138 (1997).
   Google Scholar
• Harper PS (Ed). Huntington’s Disease, 2nd Ed. WB Saunders Company, Ltd, London, UK, 28–61 (1996).
   Google Scholar
• Harper PS. What do we mean by genetic testing? J. Med. Genet.34, 749–752 (1997).
   PubMed Web of Science ®Google Scholar
• Kremer B, Goldberg P, Andrew SE et al. A worldwide study of the Huntington’s disease mutation. New Eng. J. Med.330, 1401–1406 (1994).
   PubMed Web of Science ®Google Scholar
• Kang S, Jaworski A, Ohshima K, Wells RD. Expansion and deletion of CTG repeats from human disease genes are determined by the direction of replication in E. coli. Nat. Genet.10, 213–218 (1995).
   PubMed Web of Science ®Google Scholar
• Andrew SE, Goldberg YP, Kremer B et al. Huntington disease without CAG expansion: phenocopies or errors in assignment? Am. J. Hum. Genet.54, 852–863 (1994).
   PubMed Web of Science ®Google Scholar
• Squitieri F, Gellera C, Cannella M et al. Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain126, 946–955 (2003).
   Google Scholar
• Andrew SE, Goldberg YP, Theilmann J, Zeisler J, Hayden MR. A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing. Hum. Mol. Genet.3, 65–67 (1994).
   PubMedGoogle Scholar
• Milunsky JM, Maher TA, Loose BA, Darras BT, Ito M. XL PCR for the detection of large trinucleotide expansions in juvenile Huntington’s disease. Clin. Genet.64, 70–73 (2003).
   PubMedGoogle Scholar
• Yu S, Fimmel A, Fung D, Trent RJ. Polymorphisms in the CAG repeat – a source of error in Huntington disease DNA testing. Clin. Genet.58, 469–472 (2000).
   PubMedGoogle Scholar
• Gellera C, Meioni C, Castellotti B et al. Errors in Huntington disease diagnostic test caused by trinucleotide deletion in the IT15 gene. Am. J. Hum. Genet.59, 475–477 (1996).
   PubMedGoogle Scholar
• Margolis RL, Stine OC, Callahan C et al. Two novel single base pair substitutions adjacent to the CAG repeat in the Huntington disease gene (IT15): implications for diagnostic testing. Am. J. Hum. Genet.64, 323–326 (1999).
   PubMedGoogle Scholar
• Guida M, Fenwick RG, Papp AC, Snyder PJ, Sedra M, Prior TW. Southern transfer protocol for confirmation of Huntington disease. Clin. Chem.42, 1711–1712 (1996).
   Google Scholar
• Goldberg YP, McMurray CT, Zeisler J et al. Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population. Hum. Mol. Genet.4, 1911–1918 (1995).
   PubMed Web of Science ®Google Scholar
• Moore RC, Xiang F, Monaghan J et al. Huntington disease phenocopy is a familial prion disease. Am. J. Hum. Genet.69, 1385–1388 (2001).
   PubMed Web of Science ®Google Scholar
• Williams LC, Hegde MR, Herrera G, Stapleton PM, Love DR. Comparative semi-automated analysis of (CAG) repeats in the Huntington disease gene: use of internal standards. Mol. Cell. Probes13, 283–289 (1999).
   Google Scholar
• O’Connell CD, Atha DH, Jakupciak JP, Richie KL. Standardization of PCR amplification for fragile X trinucleotide repeat measurements. Clin. Genet.61, 13–20 (2002).
   PubMed Web of Science ®Google Scholar
• College of American Pathology. Molecular genetics survey set MGL2-A. 64–68 (2002).
   Google Scholar
• Williams LC, Hedge MR, Nagappan R et al. Null alleles at the Huntington disease locus, implications for diagnostics and CAG repeat instability. Genet. Test.4, 55–60 (2000).
   PubMedGoogle Scholar
• Pelletier R, Farrell BT, Miret JJ, Lahue RS. Mechanistic features of CAG*CTG repeat contractions in cultured cells revealed by a novel genetic assay. Nucleic Acids Res.33, 5667–5676 (2005).
   PubMed Web of Science ®Google Scholar
• Cannella M, Maglione V, Martino T, Simonelli M, Ragona G, Squitieri F. New Huntington disease mutation arising from a paternal CAG34 allele showing somatic length variation in serially passaged lymphoblasts. Am J. Med. Genet. B Neuropsychiat. Genet.133, 127–130 (2005).
   Google Scholar
• Jakupciak JP, O’Connell CD. Standards and standardization of molecular diagnostics. Molecular Diagnostics for the Clinical Laboratorian, Second Edition. Tsongalis G (Ed), Humana Press, Inc., NJ, USA, 243–246 (2005).
   Google Scholar
• Brinkman RR, Mezei MM, Theilmann J, Almqvist E, Hayden MR. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am. J. Hum. Genet.60, 1202–1210 (1997).
   PubMed Web of Science ®Google Scholar
• Kooy RF, Oostra BA, Willems PJ. The fragile X syndrome and other fragile site disorders. In: Results and Problems in Cell Differentiation. Springer-Verlag, Berlin, Germany, 21, 1–46 (1998).
   Google Scholar
• Almqvist EW, Elterman DS, MacLeod PM, Hayden MR. High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia. Clin. Gene60, 198–205 (2001).
   PubMed Web of Science ®Google Scholar
• Barron LH, Warner JP, Porteous M et al. A study of the Huntington’s disease associated trinucleotide repeat in the Scottish population. J. Med. Genet.30, 1003–1007 (1993).
   Google Scholar
• Harper PS, Lim C, Crawford D. Ten years of presymptomatic testing for Huntington’s disease: the experience of the UK Huntington’s Disease Prediction Consortium. J. Med. Genet.37, 567–571 (2000).
   PubMed Web of Science ®Google Scholar
• Valdes JM, Tagle DA, Elmer LW, Collins FS. A simple non-radioactive method for diagnosis of Huntington’s disease. Hum. Mol. Genet.2, 633–634 (1993).
   Google Scholar
• Almqvist E, Spence N, Nichol K et al. Ancestral differences in the distribution of the Δ2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease. Hum. Mol. Genet.4, 207–214 (1995).
   Google Scholar
• Squitieri F, Andrew SE, Goldberg YP et al. DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence. Hum. Mol. Genet.3, 2103–2114 (1994).
   Google Scholar
• Myers RH, Marans KS, MacDonald ME. Huntington’s disease. In: Genetic Instabilities and Hereditary Neurological Diseases, Wells RD, Warren ST (Eds), Academic Press, CA, USA (1998).
   Google Scholar